Your browser doesn't support javascript.
loading
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
Saso, Wakana; Tsukuda, Senko; Ohashi, Hirofumi; Fukano, Kento; Morishita, Ryo; Matsunaga, Satoko; Ohki, Mio; Ryo, Akihide; Park, Sam-Yong; Suzuki, Ryosuke; Aizaki, Hideki; Muramatsu, Masamichi; Sureau, Camille; Wakita, Takaji; Matano, Tetsuro; Watashi, Koichi.
Affiliation
  • Saso W; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Tsukuda S; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Liver Cancer Prevention Research Unit, RIKEN Center for Integrative Medical Sciences (IMS), Wako, Japan.
  • Ohashi H; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Department of Applied Biological Sciences, Tokyo University of Science, Noda, Japan.
  • Fukano K; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Department of Analytical Biochemistry, Meiji Pharmaceutical University, Kiyose, Japan.
  • Morishita R; CellFree Sciences Co., Ltd., Matsuyama, Japan.
  • Matsunaga S; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Ohki M; Drug Design Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
  • Ryo A; Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Park SY; Drug Design Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
  • Suzuki R; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Aizaki H; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Muramatsu M; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Sureau C; Laboratoire de Virologie Moléculaire, Institut National de la Transfusion Sanguine, INSERM U1134, Paris, France.
  • Wakita T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Matano T; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Watashi K; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Department of Applied Biological Sciences, Tokyo University of Science, Noda, Japan; CREST, JST, Saitama, Japan. Electronic address: kwatashi@nih.go.jp.
Biochem Biophys Res Commun ; 501(2): 374-379, 2018 06 22.
Article in En | MEDLINE | ID: mdl-29730285
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B virus / Organic Anion Transporters, Sodium-Dependent / Symporters / High-Throughput Screening Assays / Hepatitis B Surface Antigens Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2018 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B virus / Organic Anion Transporters, Sodium-Dependent / Symporters / High-Throughput Screening Assays / Hepatitis B Surface Antigens Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2018 Document type: Article Affiliation country: Japan Country of publication: United States